Terms ending in 2031
Every in-force patent on Sanofi S.A.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D782,035 | Injection Device In force · High confidence | Sanofi S.A. | In force | High confidence | |
| US D787,047 | Injection Device In force · High confidence | Sanofi S.A. | In force | High confidence | |
| US D794,775 | Injection Device In force · High confidence | Sanofi S.A. | In force | High confidence | |
| US 8,915,246 | Dosing Device In force · High confidence | Sanofi S.A. | In force | High confidence | |
| US D802,749 | Injection Device In force · High confidence | Sanofi | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Sanofi S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.